Market revenue in 2023 | USD 98.7 million |
Market revenue in 2030 | USD 181.0 million |
Growth rate | 9.1% (CAGR from 2023 to 2030) |
Largest segment | Proteases |
Fastest growing segment | Proteases |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Proteases |
Key market players worldwide | Merck KGaA, Thermo Fisher Scientific Inc, GE HealthCare Technologies Inc Common Stock, Corning Inc, Sartorius AG, Eppendorf, Getinge AB ADR, Lonza Group Ltd, PBS Biotech, Meissner, CellGenix, Boehringer Ingelheim, Samsung BioLogics, CMC Biologics, Binex, Rentschler Biopharma SE, Toyobo Co Ltd, Innovent Biologics Inc, Roche |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to large and small-scale bioprocessing market will help companies and investors design strategic landscapes.
Proteases was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Latin America large and small-scale bioprocessing market based on proteases covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America large and small-scale bioprocessing market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America large and small-scale bioprocessing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account